Given that depression has been associated with psoriasis, Swedish researchers recently sought to elucidate the effects of gender and age. (Dermatology. 2020 Sep 14;1-8) Their analysis of ICD-10 codes and data from the Swedish Prescribed Drug Register find that women are with psoriasis are significantly more likely to be treated for depression than women without the skin disease.

Specifically, the analysis found that 21.1 percent of women with psoriasis received pharmacological treatment for depression during the study period compared to 14.2 percent in the control population. Rates for depression were significantly higher in women with psoriasis compared to men. The highest risk for depression in psoriasis patients was among male and female patients under the age of 31 years.